ATC Group: V09IX04 Fludeoxyglucose (18F)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09IX04 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09I Tumour detection
4 V09IX Other diagnostic radiopharmaceuticals for tumour detection
5 V09IX04 Fludeoxyglucose (18F)

Active ingredients in V09IX04

Active Ingredient Description
Fludeoxyglucose ยนโธF

Fludeoxyglucose F18 is a glucose analog that concentrates in cells that rely upon glucose as an energy source, or in cells whose dependence on glucose increases under pathophysiological conditions. Fludeoxyglucose F18 is used to assess glucose metabolism. It is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging.

Related product monographs

Title Information Source Document Type  
GLUSCAN Solution for injection Web Search MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Ireland (IE)

Lithuania (LT)

Malta (MT)

Romania (RO)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.